PanTheryx Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PanTheryx Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10885
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PanTheryx Inc (PanTheryx) is a medical nutrition company that research, develops and commercializes nutritional ingredients. The company’s products include foods for special dietary use, dietary supplements and medical foods. Its foods for special dietary use address the dietary needs of children with infectious diarrhea. PanTheryx’s dietary supplements are used by a healthy, non-diseased population to support intestinal health. The company’s medical foods are used for the dietary management of people with special medically-determined nutrient requirements. PanTheryx is headquartered in Boulder, Colorado, the US.

PanTheryx Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PanTheryx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PanTheryx Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PanTheryx Raises USD8.9 Million in Financing 10
PanTheryx Raises Additional USD0.6 Million in Venture Financing 11
PanTheryx Raises Additional USD0.08 Million in Venture Financing 12
PanTheryx Raises Additional USD2.91 Million in Venture Financing 13
PanTheryx Raises US$1.4 Million In Venture Financing 14
PanTheryx Raises US$3.5 Million In Venture Financing 15
Private Equity 16
Pegasus Capital Invests USD53 Million in PanTheryx 16
Licensing Agreements 17
Dr. Reddy’s Labs Enters into Licensing Agreement with PanTheryx for DiaResQ 17
PanTheryx Inc – Key Competitors 18
PanTheryx Inc – Key Employees 19
PanTheryx Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
PanTheryx Inc, Pharmaceuticals & Healthcare, Key Facts 2
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PanTheryx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PanTheryx Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PanTheryx Raises USD8.9 Million in Financing 10
PanTheryx Raises Additional USD0.6 Million in Venture Financing 11
PanTheryx Raises Additional USD0.08 Million in Venture Financing 12
PanTheryx Raises Additional USD2.91 Million in Venture Financing 13
PanTheryx Raises US$1.4 Million In Venture Financing 14
PanTheryx Raises US$3.5 Million In Venture Financing 15
Pegasus Capital Invests USD53 Million in PanTheryx 16
Dr. Reddy’s Labs Enters into Licensing Agreement with PanTheryx for DiaResQ 17
PanTheryx Inc, Key Competitors 18
PanTheryx Inc, Key Employees 19
PanTheryx Inc, Subsidiaries 20

List of Figures
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PanTheryx Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Facebook, Inc.:戦略・SWOT・企業財務分析
    Facebook, Inc. - Strategy, SWOT and Corporate Finance Report Summary Facebook, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • InterSystems Corporation:企業のM&A・提携動向(医療機器分野)
    Summary InterSystems Corporation (InterSystems) is a provider of IT solutions offering advanced data management, connectivity, and analytics technologies. It offers information engines that power important applications in the healthcare, financial services, telecommunication, governments and other s …
  • Implus Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Implus Corporation Mergers and …
  • Ellex Medical Lasers Limited (ELX):企業のM&A・提携動向(医療機器分野)
    Summary Ellex Medical Lasers Limited (Ellex) is a medical technology company that develops, manufactures, sells and distributes medical equipment for use in ophthalmic procedures. The company also offers a range of third-party medical devices and technologies. Ellex’s product portfolio includes lase …
  • Metalico Inc:企業の戦略的SWOT分析
    Metalico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ingram Micro Inc.:企業の戦略・SWOT・財務情報
    Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vast Resources Plc:企業の戦略・SWOT・財務情報
    Vast Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vast Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Anchor Therapeutics, Inc.(製薬・医療分野):企業M&A動向
    Summary Anchor Therapeutics, Inc. (Anchor) is a drug manufacturing company. The company designs and develops peptide modulators of G protein-coupled receptors. Its products are pepducin sequence desgin, pepducin research tools, in vito studies, and G protein-coupled receptors. Anchor discovers and d …
  • Covance Inc:医療機器:M&Aディール及び事業提携情報
    Summary Covance Inc (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research and manufacturing services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. I …
  • China Energy Limited (A0G):企業概要、財務及び戦略的SWOT分析
    Summary China Energy Limited (CEL) is a producer of dimethyl ether. The company offers products such as dimethyl ether and methanol. It produces methyl alcohol that is used in the production of other chemicals. CEL produces dimethyl ether from natural gas, coal or biomass through gas synthesis. The …
  • Laboratoires Thea SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoires Thea SA (Thea) is an independent pharmaceutical company that researches, develops, manufactures, and commercializes a range of eye care products. The company’s products find application in the diagnosis, surgery and treatment of ophthalmic diseases such as dry eye, allergies, gl …
  • CRA International, Inc. (CRAI):企業の財務及び戦略的SWOT分析
    Summary CRA International, Inc. (CRA) is a consulting firm that provides economic, financial, and strategic expertise to law firms, corporations, accounting firms and governments. The firm offers services such as accounting and forensic services, antitrust and competition, auctions and competitive b …
  • Alfa Wassermann SpA:企業のM&A・提携動向(医療分野)
    Summary Alfa Wassermann SpA (Alfa Wassermann) is a pharmaceutical company that research, produces and distributes drugs for human health. The company offers new discoveries in medicine, biology and genomics. It provides self-medication products for treatment of sore throat, headaches, and muscle and …
  • Brammer Plc (BRAM):企業の財務及び戦略的SWOT分析
    Summary Brammer Plc (Brammer) is an MRO distribution company that offers industrial maintenance, repair and overhaul product distributor. The company offers products such as bearings and seals, mechanical power transmission, electrical power transmission, fluid power and tools and maintenance. It se …
  • W.W. Grainger, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' W.W. Grainger, Inc. Mergers and …
  • Aemetis, Inc. (AMTX):企業概要、財務及び戦略的SWOT分析
    Summary Aemetis, Inc. (Aemetis) is an industrial biotechnology company. The company produces and markets renewable fuels, food and feed products, and biochemicals. It concentrates on the acquisition, development and commercialization of industrial biotechnologies that produces renewable chemical and …
  • Wazee Companies, LLC:企業のM&A・提携動向(発電分野)
    Summary Wazee Companies, LLC (Wazee), a subsidiary of The Timken Company is an industrial goods manufacturer that designs, engineers, manufactures, and markets bearings, transmissions, gearboxes, chain and related products. The company’s pre-engineered crane products include workstation cranes, mono …
  • Woodside Petroleum Ltd (WPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Woodside Petroleum Ltd (Woodside) is an independent oil and gas company that explores, develops, produces and supplies energy. It explores and produces oil and gas from a portfolio of facilities in association with some of the world’s major oil and gas companies. The company operates liquefi …
  • Malayan Insurance Co. Inc.:企業の戦略・SWOT・財務情報
    Malayan Insurance Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary Malayan Insurance Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Camber Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Camber Corporation Mergers and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆